<DOC>
	<DOCNO>NCT00061802</DOCNO>
	<brief_summary>A study evaluate efficacy safety two atypical antipsychotic vs. placebo patient acute exacerbation either schizophrenia schizoaffective disorder</brief_summary>
	<brief_title>Efficacy Safety Two Atypical Antipsychotics v . Placebo Patients With Acute Exacerbation Either Schizophrenia Schizoaffective Disorder</brief_title>
	<detailed_description>This study intend compare efficacy safety risperidone , quetiapine , placebo treatment patient acute exacerbation schizophrenia schizoaffective disorder . The primary tested hypothesis comparison efficacy risperidone quetiapine ( active combine group ) placebo . Other priori hypothesis test included comparison onset antipsychotic effect risperidone quetiapine placebo , evaluate efficacy , safety , cost risperidone compare quetiapine treatment subject acute exacerbation schizophrenia schizoaffective disorder . During first phase study ( 15 day ) , patient randomize risperidone titrate 1 mg 4 mg 1 mg 6 mg per day , depend body weight . Patients randomized quetiapine titrate 50 mg 400 mg 50 mg 600 mg per day , depend body weight . Based investigator determination patient clinical response , patient quetiapine group could titrate maximum 600 mg 800 mg per day depend body weight . During second phase study ( day 15 - 42 ) , patient continue take dose study medication take first phase , additional psychotropic medication could add clinically necessary control symptoms patient remain sufficiently symptomatic ( define certain minimum value clinical global severity scale . )</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Current diagnosis acute exacerbation either schizophrenia schizoaffective disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2012</verification_date>
</DOC>